For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Growth Hormone Secretagogues

CJC-1295/Ipamorelin

Also known as: CJC-1295 (no DAC) + Ipamorelin blend

A grey-market pre-mixed blend of CJC-1295 (no DAC / Modified GRF 1-29), a GHRH analog, and Ipamorelin, a selective ghrelin-receptor agonist. The blend itself is NOT clinically validated — no controlled human trial has tested this specific combination. The pharmacological rationale (GHRH + GHRP synergy for pulsatile GH amplification) is inferred from studies of other GHRH/GHRP pairs.

Real-time market data

Pricing for CJC-1295/Ipamorelin

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$7.36/mg

range $0.89–$53.99/mg

Sellers

73

from $0.60

45-day trend

-6.3%

vs 45-day avg $/mg

58 of 73 sellers have a current price· 45 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for CJC-1295/Ipamorelin

68 third-party tests across 23 vendors. Each card links to the full report.

All 68 COAs for CJC-1295/Ipamorelin →
Measured purity 98.7%–99.9% across 29 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.00 %
Jun 2026
Ethos Analytics Strong

For

CJC-1295/Ipamorelin

by OROS Research· batch OR-LPCJCIPA10-526-B10

Aggregated · 3rd-party listing
99.00 %
May 2026
Ethos Analytics Strong · HPLC

For

CJC-1295/Ipamorelin

by OROS Research· batch OR-LPCJCIPA10-526-B9

Aggregated · 3rd-party listing
99.57 %
May 2026
ILS Labs Strong

For

Ipamorelin/CJC-1295

by Sunrise Bioresearch· batch CP10MAY26-01

Aggregated · 3rd-party listing
99.53 %
Apr 2026
ILS Labs Strong

For

CJC/IPA

by Riptide Wellness· batch RWCP-10-1003

Aggregated · 3rd-party listing
99.60 %
Apr 2026
ILS Labs Strong

For

CJC / Ipamorelin

by NG Peptide· batch CJPA10-03

Aggregated · 3rd-party listing
99.00 %
Apr 2026
Ethos Analytics Strong · HPLC

For

CJC-1295/Ipamorelin

by OROS Research· batch OR-LPCJCIPA10-326-B8

Aggregated · 3rd-party listing
99.00 %
Apr 2026
Ethos Analytics Strong · HPLC

For

CJC-1295/Ipamorelin

by OROS Research· batch OR-LPCJCIPA20-326-B2

Aggregated · 3rd-party listing
99.79 %
Apr 2026
Kovera Labs

For

CJC-1295 (No DAC)/Ipamorelin

by Ion Peptide· batch CP10-04042026

Aggregated · 3rd-party listing
99.93 %
Apr 2026
Freedom Diagnostics Moderate · HPLC

For

Ipamorelin/CJC-1295

by Blank Peptides· batch 665394

Aggregated · 3rd-party listing
99.94 %
Apr 2026
Biogenica Labs · HPLC

For

CJC-1295 / Ipamorelin (No DAC)

by Amino Club· batch CIP0001

Aggregated · 3rd-party listing
99.90 %
Apr 2026
BTLabs Moderate · HPLC

For

CJC-1295/Ipamorelin

by Crush Research· batch CR-CJIP20-2603-1

Aggregated · 3rd-party listing
99.82 %
Mar 2026
Kovera Labs

For

CJC-1295 (No DAC)/Ipamorelin

by Ion Peptide· batch CP10-03262026

Aggregated · 3rd-party listing
99.75 %
Mar 2026
Kovera Labs

For

CJC-1295 (No DAC)/Ipamorelin

by Ion Peptide· batch CP-10-03242026

Aggregated · 3rd-party listing
99.87 %
Mar 2026
Kovera Labs

For

CJC-1295 (No DAC)/Ipamorelin

by Mile High Compounds· batch CIB-010-MH-01

Aggregated · 3rd-party listing
99.92 %
Mar 2026
Kovera Labs

For

CJC-1295 (No DAC)/Ipamorelin

by Glacier Aminos· batch CJIP10GA-03

Aggregated · 3rd-party listing
99.80 %
Feb 2026
Vanguard Laboratory Strong

For

CJC-1295/Ipamorelin

by Peptidology· batch 1668

Aggregated · 3rd-party listing
99.79 %
Feb 2026
Freedom Diagnostics Moderate

For

CJC-1295 + Ipamorelin (no dac)

by Nox Amino· batch NA-CP0226-01

Aggregated · 3rd-party listing
99.35 %
Feb 2026
Vanguard Laboratory Strong

For

CJC-1295/Ipamorelin

by Peptidology· batch 1669

Aggregated · 3rd-party listing
99.77 %
Jan 2026
Freedom Diagnostics Moderate · HPLC

For

Ipamorelin/CJC-1295 (NO DAC)

by Simple Peptide· batch IPCJD12720263

✓ Vendor-published
99.90 %
Jan 2026
Freedom Diagnostics Moderate

For

CJC-1295/Ipamorelin

by Sunrise Bioresearch· batch CP10JAN2601-01

COA on file
Aggregated · 3rd-party listing
99.90 %
Jan 2026
Freedom Diagnostics Moderate · HPLC

For

Ipamorelin/CJC-1295

by Crush Research· batch CR-CJIP10-260101

Aggregated · 3rd-party listing
99.90 %
Jan 2026
Freedom Diagnostics Moderate

For

Ipamorelin/CJC-1295

by Crush Research· batch CR-CJIP10-260101

Aggregated · 3rd-party listing
99.90 %
Jan 2026
Freedom Diagnostics Moderate

For

Ipamorelin/CJC-1295

by Sunrise Bioresearch· batch CP10JAN2601-01

Aggregated · 3rd-party listing
99.90 %
Jan 2026
Freedom Diagnostics Moderate

For

Ipamorelin/CJC-1295

by Ion Peptide· batch CP10-123125

Research depth

6 citations indexed for CJC-1295/Ipamorelin

All research on CJC-1295/Ipamorelin →

review · 2026

Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications

Background Injectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory consensus.

review · 2026

Therapeutic peptides in gerontology: mechanisms and applications for healthy aging

Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.

review · 2026

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

Background Therapeutic peptides are short-chain amino acids that regulate cellular functions and facilitate biochemical processes. In recent years, there has been significant growth in the global market for therapeutic peptides and thus its popularity among patients.

Study · 2026

Injuries, Injections, and Internet Forums: A Qualitative Study of Reddit User Perspectives on Peptide Therapy After Orthopaedic Surgery

review · 2026

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.

Study · 2022

Guideline-Discordant Care Among Direct-to-Consumer Testosterone Therapy Platforms